Heat Biologics Inc. | Ownership
Companies that own Heat Biologics Inc.
The Vanguard Group, Inc.
657,594
2.85%
561,571
0%
06/30/2018
Geode Capital Management LLC
122,984
0.53%
122,984
0%
06/30/2018
Virtu Financial BD LLC
71,068
0.31%
71,068
0.01%
06/30/2018
Northern Trust Investments, Inc.
51,512
0.22%
51,512
0%
06/30/2018
PanAgora Asset Management, Inc.
33,415
0.14%
12,718
0%
06/30/2018
CNB Bank
30,300
0.13%
30,300
0.04%
06/30/2018
Dimensional Fund Advisors LP
22,574
0.1%
-15,326
0%
06/30/2018
Millennium Management LLC
14,180
0.06%
14,180
0%
06/30/2018
Vanguard Fiduciary Trust Co.
4,711
0.02%
4,711
0%
06/30/2018
DWS Investment GmbH
4,000
0.02%
4,000
0%
06/30/2018
| Address |
801 Capitola Drive
Durham North Carolina 27713
United States
|
|
Employees
|
- |
| Website |
http://www.heatbio.com |
| Updated |
07/08/2019 |
| Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The firm's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the firm's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. |
